The information in the press releases on these pages was factually accurate on the date of publication. These press releases remain on AbbVie's website for historical purposes only. AbbVie assumes no duty to update the information to reflect subsequent developments. Readers should not rely upon the information in these pages as current or accurate after their publication dates.
May 30, 2019
AbbVie’s MAVIRET™ now listed in New Brunswick
April 11, 2019
AbbVie’s MAVIRET™ now reimbursed in Quebec
September 27, 2018
Health literacy still an issue in Canada
October 25, 2017
Nail psoriasis data now part of HUMIRA® label
August 8, 2017
Introducing the 2017 AbbVie IBD Scholarship recipients
January 13, 2016
ABC Life Literacy Canada moves to advance health literacy in Canada
November 18, 2015
AbbVie renews commitment to Structural Genomics Consortium
October 21, 2015
AbbVie’s HOLKIRA™ PAK Now Reimbursed in all Four Atlantic Provinces
July 24, 2015
AbbVie’s HOLKIRA™ PAK Now Reimbursed in Quebec
June 29, 2015
AbbVie’s HOLKIRA™ PAK Now Reimbursed in Ontario
Leave AbbVie.ca
You are now leaving the AbbVie.ca Web site. The AbbVie Internet site that you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals and other products or uses of those products that are not approved in Canada.
Do you wish to continue?
Exit AbbVie.ca
Notice
You are about to leave an AbbVie Canada site, a Web site maintained by AbbVie Corporation. This link is provided for your convenience only. AbbVie Corporation takes no responsibility for the content of any Web site maintained by any third party and makes no representation as to the accuracy or completeness of any information contained on this or any subsequent link.
Do you wish to leave this site?
